Cytosorbents (CTSO) Shares Outstanding (2010 - 2026)

Cytosorbents (CTSO) has reported Shares Outstanding (Entity) for 17 consecutive years, with $3.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) changed 0.37% year-over-year to $3.1 million; the trailing twelve-month figure through Jun 2026 stood at $3.1 million (changed 0.37% YoY), and the FY2025 full-year result was $3.1 million, up 14.54% from the prior year.
• Shares Outstanding (Entity) was little changed at $3.1 million in Q2 2026 per CTSO's latest filing, from $3.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $3.1 million in Q2 2026 and bottomed at $2.2 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $2.6 million across 5 years, with a median of $2.7 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) advanced 24.28% in 2024, then advanced 0.33% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $2.2 million in 2022, then advanced by 2.34% to $2.2 million in 2023, then advanced by 22.78% to $2.7 million in 2024, then rose by 14.54% to $3.1 million in 2025, then advanced by 0.06% to $3.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $3.1 million, $3.1 million, and $3.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.